Here are relevant reports on : parkinsons-disease-market
-
Neurosurgery Devices Market by Product (Neuromodulation(Spinal Cord Stimulation, Deep Brain Stimulation) Neuroendoscopy), Application (Chronic Pain, Depression, Parkinsons, Ischemia, Transnasal Neuroendoscopy), Region - Global Forecast to 2024
The Neurosurgery Devices Market is expected to grow from USD 7.3 billion in 2019 to USD 13.5 billion by 2024, at a CAGR of 13.0% during the forecast period. Major players operating in the neurosurgery devices market include B. Braun Melsungen (Germany), Medtronic (US), Boston Scientific Corporation (US), Nevro Corporation (US), KARL STORZ (Germany), Abbott (US), Ackermann Instrumente (Germany), Hawk (China), Machida Endoscope (Japan), and adeor Medical (Germany).
- Published: September 2019
- Price: $ 4950
- TOC Available:
-
Poultry Medicine/Pharmaceuticals Market by Animal Type (Chickens, Turkeys, Ducks), Product (Drugs, Vaccines, Feed Additives), Disease Indication (Newcastle disease, Infectious Bursal Disease, Salmonella), Route of Administration - Global Forecast to 2029
The global poultry medicine/pharmaceuticals market, valued at US$4.73 billion in 2023, stood at US$5.01 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2029, culminating in a forecasted valuation of US$6.68 billion by the end of the period. The growth of the poultry medicine/pharmaceutical industry can be attributed to the rising global population and consumption of poultry meat and eggs leading to more poultry farming practiced notably in the developing regions where poultry is the cheapest source of protein.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
PTA Balloon Catheter Market by Type (Polyurethane, Nylon), Application (Coronary Artery Disease, Peripheral Vascular Disease), End User (Hospitals, Ambulatory Surgical Centers), and Geography -Forecast to 2027
The global PTA balloon catheter market size is estimated to be valued at ~USD 1.8 Billion in 2021 and is expected to grow at a CAGR of 7.1% during the forecast period (2022-2027). The market is driven by factors such as rapid growth in the geriatric population and the subsequent increase in the prevalence f peripheral vascular diseases and coronary artery diseases, favorable reimbursement scenarios for peripheral vascular and coronary artery procedures, increased number of product approvals, increase the prevalence of diabetes, the rising rate of tobacco consumption, and growth in the incidences of obesity. On the other hand, a rise in the availability of alternative treatments, and a dearth of skilled professionals wth expertise in peripheral vascular devices, are expected to limit market growth to a certain extent in the coming years.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Bioresorbable Vascular Scaffold Market by Type (Metal, Polymer), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals) and Geography – Global Forecast to 2027
The global bioresorbable vascular scaffold market size is projected to reach ~USD 75 million by 2027 from ~USD 50 million in 2022, at a CAGR of 8.5% during the forecast period. The market is driven by factors such as rapidly increasing geriatric population and the risk of coronary artery diseases and peripheral artery diseases. On the other hand, product failures and withdrawals are expected to limit market growth to a certain extent in the coming years.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Europe Peritoneal Dialysis Market by Offering (Peritoneal Dialysis Solution Bags, Machines), Modality (Continuous Ambulatory Peritoneal Dialysis (CAPD)), Disease Indication (End-Stage Renal Disease), End User (Hospitals): Forecast to 2031
The Europe peritoneal dialysis market, valued at USD 2.12 billion in 2025, stood at USD 2.20 billion in 2026 and is projected to advance at a resilient CAGR of 4.3% from 2026 to 2031, culminating in a forecasted valuation of USD 2.72 billion by the end of the period. The market is driven by several factors, such as increasing prevalence of chronic kidney-related diseases, strong demand for home-based dialysis, favorable reimbursement policies, and advancements in automated peritoneal dialysis (PD) systems and remote monitoring technologies.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
US Periodontal Disease Treatment Market by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs) - Forecast to 2031
The US Periodontal Disease Treatment market, valued at USD 0.65 billion in 2025, stood at USD 0.68 billion in 2026 and is projected to advance at a resilient CAGR of 5.5% from 2026 to 2031, culminating in a forecasted valuation of USD 0.94 billion by the end of the period. Periodontal disease treatment in the US encompasses a wide range of technologies and solutions designed to support the diagnosis, treatment, and long-term management of gum-related conditions in dental practices.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Conjugate Vaccines Market by Disease (Pneumococcal, DTP, Meningococcal Disease), Type (Monovalent, Multivalent), End User (Adult, Pediatric) - Forecast to 2030
The global conjugate vaccines market, valued at US$15.86 billion in 2024, stood at US$15.25 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$21.77 billion by the end of the period. The conjugate vaccines market is growing rapidly, driven by the rising prevalence of bacterial infections like pneumococcal, meningococcal, and Hemophilus influenzae type b (Hib), rising government immunization programs and policies, innovations in vaccine technology such as multivalent formulations, increased regulatory approvals for new products, and growing investments in research, development, and international collaborations.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Peritoneal Dialysis Market by Offering (Peritoneal Dialysis Solution Bags, Machines), Modality (Continuous Ambulatory Peritoneal Dialysis Center(CAPD)), Disease Indication (End-Stage Renal Disease), End User (Hospitals) - Global Forecast to 2029
The global peritoneal dialysis market, valued at US$9.12 billion in 2023, stood at US$9.58 billion in 2024 and is projected to advance at a resilient CAGR of 5.8% from 2024 to 2029, culminating in a forecasted valuation of US$12.70 billion by the end of the period. Market growth in the Asia Pacific is attributed to the rising prevalence of acute kidney diseases, improving healthcare expenditure, and the growing accessibility of dialysis for ESRD treatment.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
North America Respiratory Care Device Market by Product (PAP Device, Ventilator, Humidifier, Oxygen Concentrator, Spirometer, Peak Flow Meter, Mask), Disease Indication (Asthma, Infectious Disease), End User (Hospital, Homecare Setting)-Forecast to 2031
The North America Respiratory Care Device market, valued at US$9.88 billion in 2025, stood at US$10.53 billion in 2026 and is projected to advance at a resilient CAGR of 7.8% from 2026 to 2031, culminating in a forecasted valuation of US$15.31 billion by the end of the period. The North America respiratory care devices market has been growing as the number of chronic respiratory diseases, such as COPD, asthma, and sleep apnea, continues to rise.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Human Microbiome Manufacturing Services Market by Type (Fermentation & Downstream Processing, Strain Development & Optimization), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Disease) - Global Forecast to 2031
The global Human Microbiome Manufacturing Services market, valued at US$0.09 billion in 2024, stood at US$0.11 billion in 2025 and is projected to advance at a resilient CAGR of 16.7% from 2025 to 2031, culminating in a forecasted valuation of US$0.27 billion by the end of the period. Growing demand for specialized capabilities, such as anaerobic fermentation, microbial process scale-up, formulation, and fill-finish, is fueling broader adoption of human microbiome manufacturing services.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
